Your browser doesn't support javascript.
loading
Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer.
Fu, Maoyong; Maresh, Erin L; Helguera, Gustavo F; Kiyohara, Meagan; Qin, Yu; Ashki, Negin; Daniels-Wells, Tracy R; Aziz, Najib; Gordon, Lynn K; Braun, Jonathan; Elshimali, Yahya; Soslow, Robert A; Penichet, Manuel L; Goodglick, Lee; Wadehra, Madhuri.
Afiliação
  • Fu M; Authors' Affiliations: Departments of Pathology and Laboratory Medicine, Surgery, Division of Surgical Oncology, Ophthalmology, and Microbiology, Immunology, and Molecular Genetics, and Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA; Department of Surgery, Greater Los Angeles Veterans Affairs Healthcare System; Department of Pathology, Charles Drew University, Los Angeles, California; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New Yor
Mol Cancer Ther ; 13(4): 902-15, 2014 Apr.
Article em En | MEDLINE | ID: mdl-24448822

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Glicoproteínas de Membrana / Carcinoma Ductal de Mama / Neoplasias de Mama Triplo Negativas / Neoplasias Pulmonares / Anticorpos Monoclonais / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Glicoproteínas de Membrana / Carcinoma Ductal de Mama / Neoplasias de Mama Triplo Negativas / Neoplasias Pulmonares / Anticorpos Monoclonais / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2014 Tipo de documento: Article